4H-FURO[3,2-C]PYRAN-2(6H)-ONE, 4-HYDROXY-, 99%, 25mg

(2R)-3-({2-amino-9-[(4-fluorophenyl)methyl]-6-oxo-6,9-dihydro-3H-purin-8-yl}sulfanyl)-2-acetamidopropanoic acid, 98%, 100mg

4-Methoxypyrimidine-2-carboxylic acid, 95.0%, 100mg

7-fLuoro-3-iodo-5-nitroindazole, 98%, 1g

N1-(2-(dimethylamino)ethyl)-N3,N3-dimethylpropane-1,3-diamine, 98%, 100mg

Zoledronic Acid Monohydrate>98.0%(HPLC)(T)1g

N-methoxy-N,1-dimethyl-1H-pyrazole-5-carboxamide, 95+%, 2g

6-Cyano-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-(pentan-3-yl)-1H-indole-4-carboxamide, 98%, 50mg

Porte-rouleau mural 1 pièce

(S)-5-(1,3-Bis(tert-butoxycarbonyl)guanidino)-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 250mg

6-Chloroindole-5-carbonitrile, 97.0%, 250mg

3-Fluoroazetidine-1-sulfonyl chloride, 98%, 100mg

1-(4-Aminopiperidin-1-yl)-2,2,2-trifluoroethan-1-one hydrochloride, 97%, 5g